CONFERENCE COMMITTEE REP. NO. 21-18

Honolulu, Hawaii

, 2018

RE: H.B. No. 1602

H.D. 2

S.D. 1

C.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Honorable Ronald D. Kouchi

President of the Senate

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sirs:

Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 1602, H.D. 2, S.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO OPIOIDS,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

The purpose of this measure is to require:

(1) The inclusion of a label warning of the risks of addiction and overdose on the packaging of any opioid drug dispensed by a health care professional or pharmacist; and

(2) A health care professional or pharmacist to include the warning in an acknowledgment signed by the patient or person receiving the opioid drug for the patient.

Your Committee on Conference has amended this measure by:

(1) Placing the new section in Chapter 329, Uniform Controlled Substances Act, instead of Chapter 329E, Overdose Prevention and Emergency Response Act;

(2) Changing the proposed warning to read, "Caution: Opioid. Risk of overdose and addiction.";

(3) Removing the requirement for health care professionals and pharmacists to provide a written acknowledgment signed by the health care professional or pharmacist, and the patient or person receiving the opioid drug for the patient, prior to dispensing of the opioid drug;

(4) Changing the effective date to upon approval; provided that the warning label requirement is implemented commencing August 1, 2018; and

(5) Making technical, nonsubstantive amendments for the purpose of clarity, consistency, and style.

As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 1602, H.D. 2, S.D. 1, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 1602, H.D. 2, S.D. 1, C.D. 1.

Respectfully submitted on behalf of the managers:

ON THE PART OF THE SENATE

ON THE PART OF THE HOUSE

____________________________ ROSALYN H. BAKER Chair	____________________________ JOHN M. MIZUNO Co-Chair
	____________________________ ROY M. TAKUMI Co-Chair